HF
FBLG icon

HRT Financial’s FibroBiologics FBLG Stock Holding History

HRT Financial’s Portfolio FBLG Stock Details FBLG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-2,207
Closed -$24K – 4196
2025
Q3 		$24K Buy
2,207
+317
+17% +$3.8K ﹤0.01% 2686
2025
Q2 		$23K Buy
+1,890
New +$34.1K ﹤0.01% 2388
2024
Q2 		– Sell
-2,867
Closed -$619K – 3254
2024
Q1 		$619K Buy
+2,867
New +$689K ﹤0.01% 1142

Other funds holding FBLG

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
CFP
Cascade Financial Partners San Diego, California $970M AUM 19.9% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
ANTB
AMG National Trust Bank Greenwood Village, Colorado $4.61B AUM 19.2% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

HRT Financial's FBLG Position: Q4 2025 in Review

HRT Financial sold out of FibroBiologics (FBLG) in Q4 2025, closing a stake of 2,207 shares — an estimated $24K sold.

HRT Financial first reported a position in FBLG in Q1 2024 and held it in 3 quarters. The position peaked at $619K in Q1 2024. 45 funds tracked by Wall St. Rank hold FBLG as of Q4 2025.

  • HRT Financial reported no remaining FibroBiologics position as of Q4 2025 after selling out during the quarter.
  • HRT Financial sold 2,207 FibroBiologics shares in Q4 2025, an estimated $24K.
  • HRT Financial first reported a position in FibroBiologics in Q1 2024 and held it in 3 quarters.
  • HRT Financial's FibroBiologics position peaked at $619K in Q1 2024.
  • 45 funds tracked by Wall St. Rank held FibroBiologics as of Q4 2025.

Based on HRT Financial's 13F filing for Q4 2025, filed 12 Feb 2026.